Mohan Sellappan

Flavonoids (polyphenols) do have their entire sort of insulin inception like action genetically on β- cells of islets of langerhans, and then decline blood glucose level to an optimum. Researches over few flavonoids like diosmin, fisetin, morin, hesperidin, naringenin etc., perceived to have insulin secreting and utilizing action in pancreatic cells and peripheral tissues glucose respectively. For this reason only, exploitation of these polyphenols in treating diabetes is highly beneficial, and it is rarely pronounced on its experimental front in recent times. Though vincristine (vincristine tablets) a natural alkaloid obtained from periwinkle plant has been contemporary, in place for treating Hodgkin’s lymphoma clinically, and found to be the most successful modern medicine. Similarly, may be flavonoids do have a very huge potential, for treating diabetes clinically with therapeutic significance, if the area of interest of flavonoids focused on diabetic management. At the same time as, fundamental research performed on these flavonoids suggests that, the flavonoids mechanisms of action are manifold. Typically mechanisms of flavonoids on glucose metabolisms are insulin uptake in skeletal muscles, regulating rate-limiting enzymes in carbohydrate metabolic pathways, insulin mimetic and secretagogue action. Hence, in this hypothesis we suggest that, managing diabetes and its complications with one or more flavonoids as a novel dosage form, having various facets of glucose metabolism regulation with regards to insulin secretion, mimic and utilization, as it would be a novel approach in treating diabetes.

A specific and accurate reverse phase high performance liquid chromatographic method was developed for the simultaneous determination Ebastine (EBA) and Montelukast Sodium (MONTE) in Combined dosage forms. The analysis was carried out using Phenomenex  C18, column (250 mm × 4.6 mm id, 5 µm particle size) with Mobile phase consisting of  Methanol : Phosphate buffer (65:35 v/v) pH 5.0+0.05 was  pumped at a flow rate was 1.0 ml/ min and  Quantification was achieved with photodiode array (PDA) detection at 261 nm over the concentration range of 10 - 50 µg/mL for ebastine & Montelukast Sodium  with mean recovery of 100.32 ± 0.85 % and 100.15 ± 0.94 % for Ebastine and Montelukast Sodium, respectively. These methods were found to be simple, sensitive, accurate, precise and economical and applicable for the simultaneous determination of Ebastine & Montelukast Sodium in combined dosage form.

The manuscript describes validated Reverse Phase High Performance Liquid Chromatographic (RP-HPLC) method for the simultaneous estimation of Perindopril Erbumine and Indapamide in combined dosage form. The RP-HPLC separation was achieved on Intersil ODS C18 column (250 mm x 4.6 mm i.d., 5 µm particle size) at 40oC using mobile phase Acetonitrile : Acid Phthalate Buffer (pH 3.0 ± 0.05) (50 :50, v/v) at flow rate 1.0 mL/min. Quantification was achieved with photodiode array (PDA) detection at 240 nm over the concentration range of 10 - 50 µg/mL for Perindopril Erbumine and 3 - 15 µg/mL for Indapamide with mean recovery of 100.09 ± 0.52 % and 100.13 ± 0.09 % for Perindopril Erbumine and Indapamide, respectively. These methods were found to be simple, sensitive, accurate, precise and economical and applicable for the simultaneous determination of Perindopril Erbumine and Indapamide in combined dosage form.

The manuscript describes validated simultaneous equation method for the simultaneous estimation of Amlodipine Besylate and Indapamide in combined dosage form. Simultaneous equation method was based on the estimation of both the drugs at two wavelengths i.e. absorption maxima of both drugs. An absorption maxima of Amlodipine besylate was 240 nm and absorption maxima of Indapamide was 215 nm in methanol. The linearity was obtained over the concentration range of 10 – 30 µg/mL for amlodipine besylate and 2 – 10 µg/mL for Indapamide with mean recovery of 99.45 ± 0.84 % and 99.46 ± 0.33 % for Amlodipine Besylate and Indapamide, respectively. These methods were found to be simple, sensitive, accurate, precise and economical and applicable for the simultaneous determination of Amlodipine Besylate and Indapamide in combined dosage form.